TELA
TELA Bio Inc.
$1.25
+$0.02(+1.63%)
43
Overall
40
Value
36
Tech
55
Quality
Market Cap
$57.05M
Volume
38.53K
52W Range
$0.87 - $3.26
Target Price
$5.40
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $15.4M | $18.2M | $29.5M | $41.4M | $58.5M | $69.3M | ||
| Total Revenue | $15.4M | $18.2M | $29.5M | $41.4M | $58.5M | $69.3M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $5.9M | $7.0M | $10.7M | $14.4M | $18.4M | $22.4M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $9.6M | $11.2M | $18.8M | $27.0M | $40.1M | $46.5M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $28.4M | $36.5M | $48.3M | $66.1M | $84.2M | $88.2M | ||
| Research & Development | $11.9M | $4.3M | $6.7M | $8.9M | $9.6M | $8.8M | ||
| Research Expense | $4.2M | $4.3M | $6.7M | $8.9M | $9.6M | $8.8M | ||
| Selling, General & Administrative | $24.3M | $32.3M | $41.5M | $57.1M | $74.6M | $79.4M | ||
| Selling & Marketing Expenses | $18.1M | $22.1M | $29.1M | $43.3M | $59.7M | $64.6M | ||
| General & Administrative Expenses | $6.2M | $10.1M | $12.5M | $13.9M | $14.9M | $14.7M | ||
| Depreciation & Amortization | $300.0K | $221.0K | $231.0K | $383.0K | $428.0K | $632.0K | ||
| Depreciation & Amortization | $300.0K | $221.0K | $231.0K | $800.0K | -- | -- | ||
| Amortization | $300.0K | $304.0K | $300.0K | $800.0K | $400.0K | $800.0K | ||
| Securities Amortization | -- | -- | -- | -- | -- | $400.0K | ||
| Other Operating Expenses | $300.0K | $300.0K | $300.0K | -- | $400.0K | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-19.2M | $-25.3M | $-29.5M | $-39.0M | $-44.1M | $-34.1M | ||
| EBITDA | $-26.0M | $-24.7M | $-29.1M | $-39.0M | $-40.6M | $-39.3M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $3.6M | $3.6M | $3.6M | $4.1M | $5.2M | $5.3M | ||
| Net Non-Operating Interest Income/Expense | $-3.6M | $-3.6M | $-3.6M | $-4.1M | $-5.2M | $-5.3M | ||
| Other Income/Expense | $-346.0K | $-45.0K | $228.0K | $-1.2M | $-2.6M | $-1.4M | ||
| Other Special Charges | $346.0K | $45.0K | $-228.0K | $-1.2M | $2.6M | $1.4M | ||
| SPECIAL ITEMS | ||||||||
| Special Income Charges | -- | $-304.0K | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-26.6M | $-25.2M | $-29.7M | $-40.2M | $-41.4M | $-40.3M | ||
| Pre-Tax Income | $-30.2M | $-28.8M | $-33.3M | $-44.3M | $-46.7M | $-38.0M | ||
| INCOME TAX | ||||||||
| Tax Provision | -- | -- | -- | -- | -- | $-144.0K | ||
| NET INCOME | ||||||||
| Net Income | $-22.4M | $-28.8M | $-33.3M | $-44.3M | $-46.7M | $-37.8M | ||
| Net Income (Continuing Operations) | $-22.4M | $-28.8M | $-33.3M | $-44.3M | $-46.7M | $-45.4M | ||
| Net Income (Discontinued Operations) | $-22.4M | $-28.8M | $-33.3M | $-44.3M | $-46.7M | $-37.8M | ||
| Net Income (Common Stockholders) | $-30.2M | $-28.8M | $-33.3M | $-44.3M | $-46.7M | $-37.8M | ||
| TOTALS | ||||||||
| Total Expenses | $34.3M | $43.2M | $58.6M | $80.4M | $102.5M | $110.6M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $1.8M | $12.9M | $14.5M | $16.3M | $22.9M | $28.5M | ||
| Average Shares Outstanding (Diluted) | $1.8M | $12.9M | $14.5M | $16.3M | $22.9M | $28.5M | ||
| Shares Outstanding | $11.4M | $14.4M | $14.6M | $19.2M | $24.6M | $39.6M | ||
| Basic EPS | $-17.1 | $-2.23 | $-2.3 | $-2.72 | $-2.04 | $-1.33 | ||
| Basic EPS (Continuing Operations) | $-17.1 | $-2.23 | $-2.3 | $-2.72 | $-2.04 | $-1.33 | ||
| Diluted EPS | $-17.1 | $-2.23 | $-2.3 | $-2.72 | $-2.04 | $-1.33 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-2.3 | $-2.72 | $-2.04 | $-1.33 | ||
| OTHER METRICS | ||||||||
| Accretion On Preferred Stock | $7.8M | -- | -- | -- | -- | -- | ||
| Development Expense | $7.8M | -- | -- | -- | -- | -- | ||
| Fees | $-7.8M | -- | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | -- | -- | $7.6M | ||
| Loss And Loss Adjustment Expected Incurred | $304.0K | -- | -- | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | -- | $7.6M | ||
| Other Gand A | $6.2M | $10.1M | $12.5M | $13.9M | $14.9M | $14.7M | ||
| Other Write Down | -- | -- | $300.0K | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | $7.8M | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $7.8M | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | $304.0K | -- | -- | -- | -- | ||
| Othspecchg | -- | $304.0K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TELA | $1.25 | +1.6% | 38.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |